Welcome to our dedicated page for R1 Rcm news (Ticker: RCM), a resource for investors and traders seeking the latest updates and insights on R1 Rcm stock.
R1 RCM Inc. (RCM) delivers technology-driven revenue cycle management solutions that help healthcare providers optimize financial performance. This news hub provides investors and industry professionals with timely updates on operational milestones, strategic partnerships, and financial developments shaping this healthcare IT leader.
Access official press releases and curated analysis covering earnings reports, technology innovations, regulatory compliance updates, and client success stories. Our repository simplifies tracking R1 RCM's progress in automating healthcare revenue cycles through AI-powered platforms and scalable operational models.
Key content areas include financial disclosures, partnership announcements with health systems, platform enhancements, and industry recognition. Bookmark this page for centralized access to verified information about R1 RCM's role in transforming healthcare financial operations.
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has entered into a definitive agreement to acquire Acclara, a leading technology-driven revenue cycle management company, from Providence, and has been selected by Providence as its long-term revenue cycle management partner. The partnership lays the foundation for R1 to continue to automate revenue management and to extend its scale and diversification to build long-term value for providers, patients, and shareholders. The proposed acquisition of Acclara and 10-year Providence partnership demonstrate the strength and flexibility of the R1 business model, and R1’s ability to deploy advanced technology solutions and drive execution across revenue cycle management processes to improve customer and patient outcomes. R1 expects the transaction to provide a foundation for additional growth opportunities by expanding the end-to-end relationship with Providence and other Acclara customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.82%
Tags
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) has completed the restatement of its financial statements for 2022 and 2021, with no material impact on revenue or Adjusted EBITDA. The restatement had no impact on the company's cash, business operations, or 2023 outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.56%
Tags
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) received a letter from Nasdaq’s Listing Qualifications Department due to a delay in filing its Quarterly Report. The delay was caused by the Company's determination to restate certain previously issued financial statements. The notice requires the Company to submit a plan to regain compliance within 60 days, with a possible extension of up to 180 days. The Company intends to file the Form 10-Q as soon as possible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) Restates Financial Statements for 2022 and 2021, No Material Impact on 2023 Results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.49%
Tags
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) to present at 2023 Stephens Annual Investment Conference and 6th Annual Evercore ISI HealthCONx Conference, offering live webcasts and replays on r1rcm.com
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
Rhea-AI Summary
R1 RCM Inc. has announced an expansion of its collaboration with Microsoft to integrate generative AI into its healthcare revenue cycle management platform. The company has launched its first large language model (LLM) application that improves physician coding quality. The application uses Microsoft Azure AI services to evaluate medical records and predict physician evaluation and management codes, improving coding quality across patient charts. R1 plans to leverage LLMs on applications across the revenue cycle to achieve greater automation and improve patient satisfaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
-
Rhea-AI Summary
R1 RCM Inc. (NASDAQ: RCM) announced its third quarter 2023 results, reporting a revenue of $572.8 million, a 15.5% increase compared to the same period last year. The company also achieved a GAAP net income of $1.3 million, compared to a net loss of $29.5 million in the same period last year. Adjusted EBITDA reached $161.5 million, a 30.2% increase compared to the same period last year. R1 expects to generate a revenue of $2,255 million to $2,275 million for 2023. The company's management team will host a conference call to discuss the financial results and business outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
-
Rhea-AI Summary
R1 RCM Inc. to release financial results for Q3 2023 on November 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.22%
Tags
Rhea-AI Summary
James Hardie Industries plc has announced the appointment of Rachel Wilson as Chief Financial Officer. Wilson brings over 25 years of experience in the technology, business services, and consumer products industries. She will report directly to CEO Aaron Erter. Wilson's appointment follows the departure of Jason Miele, who will remain with the company for three months as an advisor to the CEO for special projects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
R1 Rcm Inc
Nasdaq:RCM
RCM Rankings
RCM Stock Data
6.04B
198.59M
1.04%
86.91%
2.56%
Health Information Services
Services-management Services
United States
MURRAY